Create an Account
  1. Home
  2. Programs
  3. Inflammation: The next therapeutic frontier in targeting cardiovascular risk

Inflammation: The next therapeutic frontier in targeting cardiovascular risk

This series consists of an introduction, three presentations and a discussion in which four experts in this field will bring you up to date on the role of inflammation in atherosclerosis and how to translate findings from science and clinical trials into practice.

Episodes 1-5 of 5

  • The journey from hypothesis to reality on inflammation in CVDThe journey from hypothesis to reality on inflammation in CVD
    Inflammation: The next therapeutic frontier in targeting cardiovascular risk
    The journey from hypothesis to reality on inflammation in CVD
    • Paul Ridker, MD
      Paul Ridker, MD

      Paul Ridker, MD

    • prof. Paul Ridker, MD
      prof. Paul Ridker, MD

      prof. Paul Ridker, MD

  • IL as therapeutic target in inflammation and CVDIL as therapeutic target in inflammation and CVD
    Inflammation: The next therapeutic frontier in targeting cardiovascular risk
    IL-6 as therapeutic target in inflammation and CVD
    • Paul Ridker, MD
      Paul Ridker, MD

      Paul Ridker, MD

  • Inflammation and antiinflammatory therapy in CVDInflammation and antiinflammatory therapy in CVD
    Inflammation: The next therapeutic frontier in targeting cardiovascular risk
    Inflammation and anti-inflammatory therapy in CVD
    • Prof. Thomas Lüscher, MD
      Prof. Thomas Lüscher, MD

      Prof. Thomas Lüscher, MD

  • Challenges when targeting inflammation in residual CV risk Challenges when targeting inflammation in residual CV risk
    Inflammation: The next therapeutic frontier in targeting cardiovascular risk
    3 Challenges when targeting inflammation in residual CV risk
    • Prof. Filippo Crea, MD
      Prof. Filippo Crea, MD

      Prof. Filippo Crea, MD

  • Immunity and inflammation in atherosclerosis no longer just a theoryImmunity and inflammation in atherosclerosis no longer just a theory
    Inflammation: The next therapeutic frontier in targeting cardiovascular risk
    Immunity and inflammation in atherosclerosis - no longer just a theory
    • prof. Paul Ridker, MD
      prof. Paul Ridker, MD

      prof. Paul Ridker, MD

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free